LRP1 Regulates Architecture of the Vascular Wall by Controlling PDGFRβ-Dependent Phosphatidylinositol 3-Kinase Activation

被引:57
作者
Zhou, Li
Takayama, Yoshiharu
Boucher, Philippe
Tallquist, Michelle D.
Herz, Joachim
机构
[1] Department of Molecular Genetics, UT Southwestern Medical Center, Dallas, TX
[2] Department of Molecular Biology, UT Southwestern Medical Center, Dallas, TX
[3] Department of Pharmacology, University of Strasbourg, Strasbourg
来源
PLOS ONE | 2009年 / 4卷 / 09期
关键词
RECEPTOR-RELATED PROTEIN; PHOSPHOLIPASE-C-GAMMA; PHOSPHOINOSITIDE; 3-KINASE; MARFAN-SYNDROME; TGF-BETA; GROWTH-INHIBITION; MOUSE MODEL; PATHOGENESIS; CELLS; INVOLVEMENT;
D O I
10.1371/journal.pone.0006922
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Low density lipoprotein receptor-related protein 1 (LRP1) protects against atherosclerosis by regulating the activation of platelet-derived growth factor receptor beta (PDGFR beta) in vascular smooth muscle cells (SMCs). Activated PDGFR beta undergoes tyrosine phosphorylation and subsequently interacts with various signaling molecules, including phosphatidylinositol 3-kinase (PI3K), which binds to the phosphorylated tyrosine 739/750 residues in mice, and thus regulates actin polymerization and cell movement. Methods and Principal Findings: In this study, we found disorganized actin in the form of membrane ruffling and enhanced cell migration in LRP1-deficient (LRP1-/-) SMCs. Marfan syndrome-like phenotypes such as tortuous aortas, disrupted elastic layers and abnormally activated transforming growth factor beta (TGF beta) signaling are present in smooth muscle-specific LRP1 knockout (smLRP1-/-) mice. To investigate the role of LRP1-regulated PI3K activation by PDGFR beta in atherogenesis, we generated a strain of smLRP1-/- mice in which tyrosine 739/750 of the PDGFR beta had been mutated to phenylalanines (PDGFR beta F2/F2). Spontaneous atherosclerosis was significantly reduced in the absence of hypercholesterolemia in these mice compared to smLRP1-/- animals that express wild type PDGFR. Normal actin organization was restored and spontaneous SMC migration as well as PDGF-BB-induced chemotaxis was dramatically reduced, despite continued overactivation of TGF beta signaling, as indicated by high levels of nuclear phospho-Smad2. Conclusions and Significance: Our data suggest that LRP1 regulates actin organization and cell migration by controlling PDGFR beta-dependent activation of PI3K. TGF beta activation alone is not sufficient for the expression of the Marfan-like vascular phenotype. Thus, regulation of PI3 Kinase by PDGFR beta is essential for maintaining vascular integrity, and for the prevention of atherosclerosis as well as Marfan syndrome.
引用
收藏
页数:11
相关论文
共 46 条
  • [21] Phosphatidylinositol 3-kinase contributes to Erk1/Erk2 MAP kinase activation associated with hepatocyte growth factor-induced cell scattering
    Sipeki, S
    Bander, E
    Buday, L
    Farkas, G
    Bácsy, E
    Ways, DK
    Faragó, A
    CELLULAR SIGNALLING, 1999, 11 (12) : 885 - 890
  • [22] c-Abl-dependent Molecular Circuitry Involving Smad5 and Phosphatidylinositol 3-Kinase Regulates Bone Morphogenetic Protein-2-induced Osteogenesis
    Ghosh-Choudhury, Nandini
    Mandal, Chandi C.
    Das, Falguni
    Ganapathy, Suthakar
    Ahuja, Seema
    Choudhury, Goutam Ghosh
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (34) : 24503 - 24517
  • [23] Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells
    Whitley, Brandi R.
    Beaulieu, Lea M.
    Carter, Jennifer C.
    Church, Frank C.
    GYNECOLOGIC ONCOLOGY, 2007, 104 (02) : 470 - 479
  • [24] A phosphatidylinositol 3-kinase class III sub-complex containing VPS15, VPS34, Beclin 1, UVRAG and BIF-1 regulates cytokinesis and degradative endocytic traffic
    Thoresen, Sigrid B.
    Pedersen, Nina Marie
    Liestol, Knut
    Stenmark, Harald
    EXPERIMENTAL CELL RESEARCH, 2010, 316 (20) : 3368 - 3378
  • [25] Combined thiazolidinedione-metformin treatment synergistically improves insulin signalling to insulin receptor substrate-1-dependent phosphatidylinositol 3-kinase, atypical protein kinase C and protein kinase B/Akt in human diabetic muscle
    Temofonte, N.
    Sajan, M. P.
    Nimal, S.
    Pastoor, T.
    Fumero, C.
    Casaubon, L.
    Powe, J. L.
    Standaert, M. L.
    Farese, R. V.
    DIABETOLOGIA, 2009, 52 (01) : 60 - 64
  • [26] Phosphatidylinositol 3-kinase-δ up-regulates L-type Ca2+ currents and increases vascular contractility in a mouse model of type 1 diabetes
    Pinho, J. F.
    Medeiros, M. A. A.
    Capettini, L. S. A.
    Rezende, B. A.
    Campos, P. P.
    Andrade, S. P.
    Cortes, S. F.
    Cruz, J. S.
    Lemos, V. S.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (07) : 1458 - 1471
  • [27] Insulin signalling in heart involves insulin receptor substrates-1 and -2, activation of phosphatidylinositol 3-kinase and the JAK 2-growth related pathway
    Velloso, LA
    Carvalho, CRO
    Rojas, FA
    Folli, F
    Saad, MJA
    CARDIOVASCULAR RESEARCH, 1998, 40 (01) : 96 - 102
  • [28] Proteasome Inactivation Promotes p38 Mitogen-activated Protein Kinase-dependent Phosphatidylinositol 3-kinase Activation and Increases Interleukin-8 Production in Retinal Pigment Epithelial Cells
    Fernandes, Alexandre F.
    Bian, Qingning
    Jiang, Jian-Kang
    Thomas, Craig J.
    Taylor, Allen
    Pereira, Paulo
    Shang, Fu
    MOLECULAR BIOLOGY OF THE CELL, 2009, 20 (16) : 3690 - 3699
  • [29] Triptolide, a diterpenoid triepoxide, induces antitumor proliferation via activation of c-Jun NH2-terminal kinase 1 by decreasing phosphatidylinositol 3-kinase activity in human tumor cells
    Miyata, Y
    Sato, T
    Ito, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 336 (04) : 1081 - 1086
  • [30] The Farnesyltransferase Inhibitor LB42708 Suppresses Vascular Endothelial Growth Factor-Induced Angiogenesis by Inhibiting Ras-dependent Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt Signal Pathways
    Kim, Chun-Ki
    Choi, Yoon Kyung
    Lee, Hansoo
    Ha, Kwon-Soo
    Won, Moo-Ho
    Kwon, Young-Guen
    Kim, Young-Myeong
    MOLECULAR PHARMACOLOGY, 2010, 78 (01) : 142 - 150